Skip to Content
MilliporeSigma
  • Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.

Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.

Xenobiotica; the fate of foreign compounds in biological systems (2014-01-10)
Therese Ericsson, Jesper Sundell, Angelica Torkelsson, Kurt-Jürgen Hoffmann, Michael Ashton
ABSTRACT

1. Cytochrome P450 enzyme system is the most important contributor to oxidative metabolism of drugs. Modification, and more specifically inhibition, of this system is an important determinant of several drug-drug interactions (DDIs). 2. Effects of the antimalarial agent artemisinin and its structural analogues, artemether, artesunate and dihydroartemisinin, on seven of the major human liver CYP isoforms (CYP1A2, 2A6, 2B6, 2C9, 2C19, 2D6 and 3A4) were evaluated using recombinant enzymes (fluorometric assay) and human liver microsomes (LC-MS/MS analysis). Inhibitory potency (IC50) and mechanisms of inhibition were evaluated using nonlinear regression analysis. In vitro-in vivo extrapolation using the [I]/Ki ratio was applied to predict the risk of DDI in vivo. 3. All compounds tested inhibited the enzymatic activity of CYPs, mostly through a mixed type of inhibition, with CYP1A2, 2B6, 2C19 and 3A4 being affected. A high risk of interaction in vivo was predicted if artemisinin is coadministrated with CYP1A2 or 2C19 substrates. 4. With respect to CYP1A2 inhibition in vivo by artemisinin compounds, our findings are in line with previously published data. However, reported risks of interaction may be overpredicted and should be interpreted with caution.

MATERIALS
Product Number
Brand
Product Description

Coumarin, European Pharmacopoeia (EP) Reference Standard
Supelco
Phenacetin melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Phenacetin Melting Point Standard, United States Pharmacopeia (USP) Reference Standard
Paracetamol, European Pharmacopoeia (EP) Reference Standard
Supelco
Phenacetin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Coumarin, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Coumarin, primary reference standard
Sigma-Aldrich
7-Methoxy-4-(trifluoromethyl)coumarin, ≥99% (TLC)
Sigma-Aldrich
Phenacetin, ≥98.0% (HPLC)
Sigma-Aldrich
Coumarin, ≥99% (HPLC)
Sigma-Aldrich
Artemether, ≥98% (HPLC)
Sigma-Aldrich
Dextrorphan
Sigma-Aldrich
Magnesium chloride hexahydrate, 99.995% trace metals basis
Sigma-Aldrich
Magnesium chloride hexahydrate, puriss., meets analytical specification of Ph. Eur., BP, FCC, E511, 99-101%, ≤0.0001% Al
Sigma-Aldrich
Potassium phosphate monobasic, meets analytical specification of Ph. Eur., NF, E340, anhydrous, 98-100.5% (calc. to the dried substance)
Supelco
Dihydroartemisinin, analytical standard, mixture of α and β isomers
Sigma-Aldrich
Potassium phosphate monobasic, 99.99% trace metals basis
Sigma-Aldrich
Potassium phosphate monobasic, ReagentPlus®
Supelco
Tolbutamide, analytical standard
Sigma-Aldrich
7-Ethoxy-4-(trifluoromethyl)coumarin, ≥98% (TLC)
Sigma-Aldrich
Potassium phosphate dibasic, reagent grade, ≥98.0%
Sigma-Aldrich
Sulfaphenazole, ≥98%
Sigma-Aldrich
trans-2-Phenylcyclopropylamine hydrochloride
Sigma-Aldrich
Artemisinin, 98%
Sigma-Aldrich
Magnesium chloride hexahydrate, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide phosphate hydrate
Sigma-Aldrich
Potassium phosphate monobasic, powder, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
trans-2-Phenylcyclopropylamine hydrochloride, 97%
Sigma-Aldrich
Umbelliferone, 99%
Sigma-Aldrich
7-Benzyloxy-4-trifluoromethylcoumarin, ≥99% (HPLC), solid